Trial · NCT07884890
Measured Versus Hemoglobin-Calculated Postpartum Blood Loss in Waterbirth
NCT07884890, Not yet recruiting, University of Campania Luigi Vanvitelli
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Measured Versus Hemoglobin-Calculated Postpartum Blood Loss in Waterbirth. Trials, record NCT07884890. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07884890
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Measured Versus Hemoglobin-Calculated Postpartum Blood Loss in Waterbirth
- NCT number
- NCT07884890
- Status
- Not yet recruiting
- Enrollment
- 600 participants, estimated
- Lead sponsor
- University of Campania Luigi Vanvitelli
- Conditions
- Postpartum Hemorrhage, Waterbirth
- Interventions
- Water immersion during labor and birth
- First posted
- 2026-10-21
- Last updated
- 2026-10-21
Source ClinicalTrials.gov
Registered outcomes7
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Difference between calculated and measured blood loss | From admission in labor to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours) | Individual difference, in mL, between calculated blood loss and blood loss measured in the graduated collector bag. Calculated blood loss = maternal weight (kg) x 85 x (hemoglobin at admission in labor - postpartum hemoglobin) / hemoglobin at admission in labor. The difference is compared between Group A (waterbirth) and Group C (land birth without water immersion). |
| Secondary | Peripartum hemoglobin drop | From admission in labor to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours) | Hemoglobin at admission in labor minus postpartum hemoglobin, in g/dL, compared between groups. The proportion of women with a drop of 2 g/dL or more is also reported. |
| Secondary | Postpartum hemorrhage of 500 mL or more, by each assessment method | From birth to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours) | Proportion of women with blood loss of 500 mL or more, reported separately for blood loss measured in the collector bag and for calculated blood loss, and compared between groups. |
| Secondary | Postpartum hemorrhage of 1000 mL or more, by each assessment method | From birth to the postpartum hemoglobin measurement (target 48 hours after birth, accepted window 36 to 60 hours) | Proportion of women with blood loss of 1000 mL or more, reported separately for blood loss measured in the collector bag and for calculated blood loss, and compared between groups. |
| Secondary | Red blood cell transfusion | From birth to hospital discharge, an average of 3 days | Proportion of women receiving a red blood cell transfusion after birth, and number of units transfused, compared between groups. |
| Secondary | Intravenous iron administration | From birth to hospital discharge, an average of 3 days | Proportion of women receiving intravenous iron after birth, compared between groups. |
| Secondary | Duration of the third stage of labor | From birth of the baby to delivery of the placenta, up to 2 hours | Minutes between birth of the baby and delivery of the placenta, compared between Group A and Group C. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07884890
GET https://conductscience.org/api/trials/v1/NCT07884890/registered